Bayer and Atara Biotherapeutics (ATRA) Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors

Go back to Bayer and Atara Biotherapeutics (ATRA) Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors
(NASDAQ: ATRA) Delayed: 10.23 +0.47 (4.82%)
Previous Close $9.76    52 Week High $40.80 
Open $10.60    52 Week Low $12.45 
Day High $11.33    P/E N/A 
Day Low $10.23    EPS $0.00 
Volume 106,565